130 related articles for article (PubMed ID: 25608809)
1. Biological function and molecular mechanism of Twist2.
Zhao CX; Yang Z
Yi Chuan; 2015 Jan; 37(1):17-24. PubMed ID: 25608809
[TBL] [Abstract][Full Text] [Related]
2. Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription.
Franco HL; Casasnovas J; Rodríguez-Medina JR; Cadilla CL
Nucleic Acids Res; 2011 Mar; 39(4):1177-86. PubMed ID: 20935057
[TBL] [Abstract][Full Text] [Related]
3. Nonsense mutations of the bHLH transcription factor TWIST2 found in Setleis Syndrome patients cause dysregulation of periostin.
Franco HL; Casasnovas JJ; Leon RG; Friesel R; Ge Y; Desnick RJ; Cadilla CL
Int J Biochem Cell Biol; 2011 Oct; 43(10):1523-31. PubMed ID: 21801849
[TBL] [Abstract][Full Text] [Related]
4. Role of epithelial-mesenchymal transition regulated by twist basic helix-loop-helix transcription factor 2 (Twist2) in embryo implantation in mice.
Gou J; Hu T; Li L; Xue L; Zhao X; Yi T; Li Z
Reprod Fertil Dev; 2019 Apr; 31(5):932-940. PubMed ID: 30779884
[TBL] [Abstract][Full Text] [Related]
5. LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2.
Tan YE; Xing Y; Ran BL; Zhang C; Pan SW; An W; Chen QC; Xu HM
Aging (Albany NY); 2020 Nov; 12(24):25060-25075. PubMed ID: 33206629
[TBL] [Abstract][Full Text] [Related]
6. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
7. Twist2 functions as a tumor suppressor in murine osteosarcoma cells.
Ishikawa T; Shimizu T; Ueki A; Yamaguchi SI; Onishi N; Sugihara E; Kuninaka S; Miyamoto T; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Mabuchi Y; Matsuzaki Y; Yamaguchi R; Miyano S; Saya H
Cancer Sci; 2013 Jul; 104(7):880-8. PubMed ID: 23557174
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
9. Setleis syndrome: clinical, molecular and structural studies of the first TWIST2 missense mutation.
Rosti RO; Uyguner ZO; Nazarenko I; Bekerecioglu M; Cadilla CL; Ozgur H; Lee BH; Aggarwal AK; Pehlivan S; Desnick RJ
Clin Genet; 2015 Nov; 88(5):489-493. PubMed ID: 25410422
[TBL] [Abstract][Full Text] [Related]
10. TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.
Song Y; Zhang W; Zhang J; You Z; Hu T; Shao G; Zhang Z; Xu Z; Yu X
Exp Cell Res; 2021 Aug; 405(1):112661. PubMed ID: 34044016
[TBL] [Abstract][Full Text] [Related]
11. Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.
Li S; Chen K; Zhang Y; Barnes SD; Jaichander P; Zheng Y; Hassan M; Malladi VS; Skapek SX; Xu L; Bassel-Duby R; Olson EN; Liu N
Genes Dev; 2019 Jun; 33(11-12):626-640. PubMed ID: 30975722
[TBL] [Abstract][Full Text] [Related]
12. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
13. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
14. Homozygous nonsense mutations in TWIST2 cause Setleis syndrome.
Tukel T; Šošić D; Al-Gazali LI; Erazo M; Casasnovas J; Franco HL; Richardson JA; Olson EN; Cadilla CL; Desnick RJ
Am J Hum Genet; 2010 Aug; 87(2):289-96. PubMed ID: 20691403
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
16. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
17. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S
Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873
[TBL] [Abstract][Full Text] [Related]
18. Significance of heterogeneous Twist2 expression in human breast cancers.
Mao Y; Zhang N; Xu J; Ding Z; Zong R; Liu Z
PLoS One; 2012; 7(10):e48178. PubMed ID: 23133563
[TBL] [Abstract][Full Text] [Related]
19. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
[TBL] [Abstract][Full Text] [Related]
20. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
